Raniberta en es it fr

Raniberta Brand names, Raniberta Analogs

Raniberta Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Raniberta Chemical_Formula


Raniberta RX_link


Raniberta fda sheet

Raniberta FDA

Raniberta msds (material safety sheet)

Raniberta MSDS

Raniberta Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Raniberta Molecular Weight

314.405 g/mol

Raniberta Melting Point

69-70 oC

Raniberta H2O Solubility

24.7 mg/mL

Raniberta State


Raniberta LogP


Raniberta Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Raniberta Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Raniberta Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Raniberta Absorption

Approximately 50% bioavailability orally.

Raniberta side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Raniberta Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Raniberta Organisms Affected

Humans and other mammals